CVS Health Co. (NYSE:CVS) Stock Holdings Lifted by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. increased its stake in CVS Health Co. (NYSE:CVS) by 0.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 513,285 shares of the pharmacy operator’s stock after acquiring an additional 3,693 shares during the quarter. Asset Management One Co. Ltd.’s holdings in CVS Health were worth $40,534,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Live Oak Investment Partners acquired a new position in CVS Health in the 4th quarter worth approximately $25,000. Atticus Wealth Management LLC grew its holdings in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares in the last quarter. Cornerstone Planning Group LLC raised its position in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 243 shares during the period. ZRC Wealth Management LLC lifted its stake in CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 400 shares in the last quarter. Finally, True Wealth Design LLC acquired a new stake in CVS Health during the 4th quarter worth about $48,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.25% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

CVS stock traded up $0.92 during trading on Friday, hitting $74.82. The company had a trading volume of 2,345,760 shares, compared to its average volume of 11,197,037. The company has a fifty day moving average price of $76.04 and a two-hundred day moving average price of $73.72. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25. The company has a market cap of $94.16 billion, a P/E ratio of 11.44, a P/E/G ratio of 0.99 and a beta of 0.52. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the business earned $1.99 earnings per share. The business’s revenue was up 11.9% on a year-over-year basis. Equities research analysts expect that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.56%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CVS. SVB Leerink initiated coverage on shares of CVS Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price target for the company. HSBC initiated coverage on shares of CVS Health in a research report on Friday, December 22nd. They issued a “buy” rating and a $94.00 target price for the company. Barclays began coverage on shares of CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target on the stock. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Finally, TD Cowen dropped their target price on CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a research report on Monday, December 11th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $89.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.